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Introduction {#sec1}
============

Transcription plays a key role not only in gene expression, but also can affect other aspects of DNA metabolism. It has been shown to induce genome instability by increasing the rate of mutagenesis and recombination from prokaryote to eukaryotes ([@bib3], [@bib18], [@bib35]). A collateral effect of transcription is the formation of R-loops, as a result of the co-transcriptional hybridization of the nascent RNA with the DNA template ([@bib2], [@bib25]). These R-loops can play specific physiological roles, but in most cases they can constitute a source of genome instability by their ability to halt replication and subsequently cause DNA breaks ([@bib19], [@bib59], [@bib62], [@bib79]). Cells have evolved factors and mechanisms, such as RNaseH1, RNA-DNA helicases, topoisomerases, and mRNA ribonucleoprotein (mRNP) biogenesis factors, to prevent harmful R-loops ([@bib55], [@bib60], [@bib70]).

The different steps of mRNP biogenesis are tightly connected, so that there is a physical and functional link between transcription, RNA processing (5′ end-capping, splicing, and 3′ end-formation), mRNA export, and nuclear mRNA surveillance to guarantee export of functionally competent RNAs ([@bib7], [@bib57]). Cumulative evidence supports the idea that a suboptimal mRNP particle can favor the formation of harmful R-loops. The THO complex, involved in mRNP biogenesis, is a paradigm for the connection between mRNP biogenesis with the maintenance of genome integrity. Yeast and human cells lacking a functional THO complex show transcription and R-loop-mediated hyperrecombination, as well as DNA break accumulation, that associate with an increase in transcription-replication conflicts ([@bib23], [@bib30], [@bib54], [@bib77]). SRSF1, a splicing factor that regulates early splicing steps, also prevents R-loops as shown in DT40 chicken cells and human cells ([@bib39]). Genome-wide searches in yeast and human cells identified additional RNA binding and processing factors and other proteins involved in mRNP assembly that increased genome instability ([@bib48], [@bib64], [@bib75]). In addition, RNA-DNA helicases such as senataxin, DDX23, or DDX19, which function in different steps of mRNA biogenesis, also protect cells from R-loops that compromise genome instability ([@bib28], [@bib60], [@bib63]). Loss of such factors induces γH2AX, DNA breaks, hyperrecombination, chromosome loss, and/or genetic rearrangements. In most cases, overexpression of RNase H1, which specifically degrades the RNA moiety in RNA-DNA hybrids, suppresses these phenotypes and the mutant cells accumulate RNA-DNA hybrids ([@bib2]).

Chromatin may also contribute to protecting cells from R-loop accumulation. Thus, the yeast and human FACT chromatin reorganizing complex and the human mSin3A histone deacetylase prevent R-loop accumulation and/or transcription and R-loop-mediated genome instability ([@bib27], [@bib54]). Interestingly, mSin3A functions together with THO, which suggests a co-transcriptional crosstalk between THO and chromatin modification factors to promote histone deacetylation and, consequently, a transient chromatin closing as a coordinated mechanism to prevent R-loop formation.

To explore further the mechanisms by which THO prevents co-transcriptional R-loops, we searched for factors interacting physically with THO. Thus, we identified MFAP1 (microfibrillar-associated protein 1), a putative mRNA splicing factor. Interestingly, MFAP1 depletion also leads to genome instability phenotype, but this cannot be suppressed by either transcription inhibition or RNase H1 overexpression. Similar results were obtained for the yeast ortholog *SPP381* gene. Functional analysis and transcriptomics of small interfering RNA (siRNA) MFAP1-depleted HeLa cells and RNA sequencing (RNA-seq) of an *spp381* yeast mutant support that MFAP1/SPP381 affects splicing and expression of a broad number of genes including DDR genes. Our study thus supports that THO is a conserved mRNA biogenesis factor that interacts with co-transcriptional splicing factors with a distinctive role in preventing R-loop formation that do not share with other RNA-binding and processing factors.

Results {#sec2}
=======

MFAP1 Is a Spliceosome-Associated Protein that Interacts with the THO Complex {#sec2.1}
-----------------------------------------------------------------------------

To explore further how RNA binding factors could protect genome integrity during transcription, we searched for THO-interacting proteins in human cells. We carried out a two-hybrid screening using as bait the THOC1 subunit of THO fused to the DNA binding domain of Gal4 (GAL4BD-THOC1). We found a clone encoding MFAP1, presumably implicated in mRNA splicing ([@bib4], [@bib44], [@bib54], [@bib78]). To validate this interaction in human cells, we first performed co-immunoprecipitation (coIP) assays in HEK293T cells transiently transfected with a GFP-MFAP1 fusion or GFP. THOC1 was detected by immunoblot after immunoprecipitation (IP) using GFP-trap ([Figure 1](#fig1){ref-type="fig"}A). MFAP1-THOC1 interaction was confirmed by coIP with anti-MFAP1 antibody ([Figure 1](#fig1){ref-type="fig"}A, bottom panel) and by proximity ligation assay (PLA), which detects protein-protein association *in situ* ([Figure 1](#fig1){ref-type="fig"}B). A strong PLA signal was detected, confirming a close association between these factors in human cells. As expected, such association is observed exclusively in the nucleus, because both are nuclear proteins.Figure 1MFAP1 Physically Interacts with THOC1, and SF3B1 Binds to Actively Transcribed Genes and Is Localized at Nuclear Speckles(A) MFAP1 and THOC1 protein interaction detected by co-immunoprecipitation with anti-GFP antibody (GFP-trap) from whole-cell extracts of HEK293T cells transfected with pEGFP-MFAP1 for 24 h (top panel), and co-immunoprecipitation with anti-MFAP1 antibody from whole-cell extracts of HEK293T (bottom panel). Input extract and total immunoprecipitate (IP) were analyzed by western blot with anti-THOC1 antibody. Input lanes represent 1% of the amount of whole-cell extract used in each experiment (n = 2).(B) Proximity ligation assay (PLA) in HeLa cells showing specific *in situ* association of THOC1 and MFAP1 endogenous proteins. PLA signal (red spots; n = 2). Negative controls with only one of the antibodies are also shown.(C) GFP-trap assay from whole extract of cells transfected with pGEFP-MFAP1 for 24 h and immunoblot with anti-SF3B1 antibody (n = 2).(D) PLA assay in HeLa cells showing specific *in situ* association of MFAP1 and SF3B1 proteins. PLA signal (red spots) (n = 2) is shown.(E) Colocalization of endogenous MFAP1 with splicing speckles. HeLa cells were labeled by double immunofluorescence using specific antibodies against MFAP1 and the nuclear speckle marker SC35 (n = 2). Bottom panels are a magnification of the region indicated in the first top panel.(F) ChIP analysis of MFAP1 within the *β-actin* in HeLa cells. Values represent the ratios of precipitated DNA (IP) to input DNA (INPUT). The positions of amplified regions are indicated on the x axis. Mean ± SEM of three independent experiments are shown. Schematic diagram of the gene is depicted. Open boxes represent exons, and the arrow indicates the start transcription site. Numbered red lines indicate the regions where ChIP-qPCR analyses were performed.Nuclei were stained with DAPI (B, D, and E). Scale bars, 20 μm (B, D, and E).See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

Because different genome-wide approaches suggested that MFAP1 was a splicing factor ([@bib26], [@bib44]), we tested the interaction of MFAP1 with the core spliceosome protein SF3B1, a subunit of the U2 small nuclear ribonucleoprotein (snRNP). SF3B1 was enriched in the IP from cells bearing GFP-MFAP1 fusion ([Figure 1](#fig1){ref-type="fig"}C). The association between MFAP1 and SF3B1 was confirmed by PLA with anti-MFAP1 and anti-SF3B1 antibodies ([Figures 1](#fig1){ref-type="fig"}D). Interestingly, SF3B1 was shown to interact with THOC1 by coIP ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Next, we performed immunofluorescence (IF) of MFAP1 and SC35, commonly used as a marker of splicing speckles. As can be seen in [Figure 1](#fig1){ref-type="fig"}E, MFAP1 and SC35 colocalize, indicating a cytological association of MFAP1 with the spliceosome. Human THO/TREX has also been shown to localize at speckles, and there is evidence that the recruitment of this complex to chromatin is partially mediated by the capping and the splicing machineries ([@bib12], [@bib13], [@bib45]).

The interaction of the spliceosome-associated factor MFAP1 with THOC1 is consistent with the predicted role of THO in mRNA biogenesis. Next, we asked whether MFAP1 could bind to active chromatin and contribute to the loading of the THO complex or its stabilization in a chromatin-bound stage. Chromatin-IP (ChIP) analysis in highly transcribed genes such as *β-actin* and GAPDH indicated that MFAP1 is present at transcribed chromatin ([Figures 1](#fig1){ref-type="fig"}F and [S1](#mmc1){ref-type="supplementary-material"}B), but neither MFAP1 nor SF3B1 seem to be required for THOC1 loading to chromatin. Indeed, a slightly high enrichment of THOC1 was detected in siMFAP1 cells ([Figures S1](#mmc1){ref-type="supplementary-material"}C and S1D).

MFAP1 Depletion Leads to Genome Instability Independent of Transcription and RNA-DNA Hybrids {#sec2.2}
--------------------------------------------------------------------------------------------

To investigate whether MFAP1 has a role in the maintenance of genome integrity, as it is the case of THO, we determined the levels of DNA damage, as detected by γH2AX foci, in HeLa cells depleted of MFAP1. A 3.3-fold increase in the percentage of cells with γH2AX foci was observed in siMFAP1 cells with respect to the siC control ([Figure 2](#fig2){ref-type="fig"}A). Direct analysis of DNA breaks by single-cell electrophoresis confirmed a significant increase in tail moment in MFAP1 siRNA-depleted cells (5.5-fold and 2.1-fold in alkaline or neutral single-cell electrophoresis assays, respectively) consistent with an accumulation of DNA breaks ([Figures 2](#fig2){ref-type="fig"}B and 2C). The levels of sister chromatin exchange (SCE) events resulting from the recombinational repair of replication-born DNA breaks, however, showed no differences between siMFAP1 and siC control cells ([Figure S2](#mmc1){ref-type="supplementary-material"}). Finally, we assayed whether DNA breaks would lead to anaphase bridges resulting from interlinked sister-chromatid intermediates resulting from unfinished replication or incomplete DNA repair ([@bib3]). The percentage of anaphase cells containing bridges was significantly increased after MFAP1 depletion ([Figure 2](#fig2){ref-type="fig"}D). We conclude that the MFAP1 splicing factor is required for the maintenance of genome integrity, mainly by preventing the formation and/or accumulation of DNA breaks.Figure 2MFAP1 Depletion Leads to Genome Instability(A) Detection of γH2AX foci by immunofluorescence in siC- (control) and siMFAP1-transfected HeLa cells. The percentage of cells with \>5 γH2AX foci is shown. Nuclei were stained with DAPI.(B) Alkaline single-cell electrophoresis in control and MFAP1-depleted HeLa cells.(C) Neutral single-cell electrophoresis of HeLa cells transfected with the indicated siRNAs. Relative comet-tail moments are plotted (B and C).(D) Anaphase bridges in siC- and siMFAP1-transfected HeLa cells. Microphotography showing anaphase bridges in MFAP1-depleted cells. The percentages of anaphase cells with anaphase bridges are plotted.Data are plotted as mean ± SEM (n = 3). Scale bars, 20 μm (A and D) or 125 μm (B and C). ^∗^p \< 0.05 as determined by Student's t test (A and D) or Mann-Whitney U test (B and C).See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

Next, we wondered whether similar to THO-depleted cells, genome instability observed in MFAP1-depleted cells was dependent on transcription and R-loops. We performed alkaline single-cell electrophoresis in the presence of the transcription inhibitor cordycepin and γH2AX IF under overexpression of RNase H1. No significant reduction of DNA breaks was observed in cells depleted of MFAP1 after transcription inhibition ([Figure 3](#fig3){ref-type="fig"}A) or after RNase H1 overexpression ([Figure 3](#fig3){ref-type="fig"}B), in contrast with the suppression observed in cells depleted of THOC1 and other factors that prevent R-loop accumulation ([@bib16], [@bib27], [@bib20], [@bib54]), indicating that DNA breaks induced by MFAP1 depletion were not transcription dependent or mediated by R-loops. Therefore, we conclude that the effect of MFAP1 on genome instability may not be mediated by THO, because the genome instability phenotype is of a different nature. Our data suggest that the impact of MFAP1 depletion in genome integrity has to be indirect.Figure 3Genome Instability Caused by MFAP1 Depletion Is Not Associated with Transcription or R-Loop Formation(A) Alkaline comet assay in siC- and siMFAP1-transfected HeLa cells untreated or treated with 50 μM cordycepin for 4 h. Relative comet-tail moments are plotted as mean ± SEM (n = 3).(B) Immunofluorescence of γH2AX in HeLa cells after siC and siMFAP1 transfection with or without RNase H1 (RNH1) overexpression. Cells were transfected with empty pcDNA3 vector (−RNH1) or pcDNA3-RNaseH1 (+RNH1) for 24 h. Nuclei were stained with DAPI. The percentage of cells with \>5 γH2AX foci is shown. Data are plotted as mean ± SEM (n = 3).Scale bars, 125 μm (A) or 20 μm (B). ^∗^p \< 0.05 as determined by Mann-Whitney U test (A) or Student's t test (B).

Proliferation and Cell Cycle Are Impaired in MFAP1-Depleted Cells {#sec2.3}
-----------------------------------------------------------------

To gain further insight into the functional role of MFAP1, we analyzed cell proliferation and cell-cycle progression in siRNA MFAP1-depleted cells. As can be seen in [Figure 4](#fig4){ref-type="fig"}A, cell proliferation was severely affected in siMFAP1 cells. FACS analysis of asynchronously growing MFAP1-depleted HeLa cells revealed an accumulation of cells in G2 together with a decrease in S phase in MFAP1-depleted cells ([Figure 4](#fig4){ref-type="fig"}B). Cell-cycle progression analysis in G1 synchronized cells by double-thymidine block after subsequent release shows S-phase progression slowed down and an increase in the percentage of G2-arrested cells after MFAP1 depletion ([Figure 4](#fig4){ref-type="fig"}C). These phenotypes were accompanied by an increase in apoptotic cells, as measured by sub-G1 DNA content ([Figure 4](#fig4){ref-type="fig"}D). The results are consistent with the effect of MFAP1 depletion in G2/M transition described in *Drosophila* and the identification of MFAP1 in a siRNA screen for genes affecting cell division ([@bib4], [@bib37]). Therefore, our results show that depletion of MFAP1 leads to defective proliferation and cell cycle in human cells.Figure 4Defects in Cell Proliferation and Cell-Cycle Progression in MFAP1-Depleted Cells(A) Cell proliferation assays of HeLa cells after MFAP1 depletion. Cells were plated 48 h after siRNA depletion (day 0). Viable cells were those showing metabolic activity of mitochondrial dehydrogenases. Relative values were normalized to the day 0 value. The plotted values correspond to a representative experiment (n = 2).(B) FACS analysis of asynchronously growing HeLa cells depleted of MFAP1 after 20 min of incubation with 20 μM 5′-ethynyl-2-deoxyuridine (EdU). Cells at different stages of the cell cycle were distinguished based on their DNA content (7-amino-actinomycin D \[7-AAD\] staining), and replication activity was analyzed by EdU incorporation. Data are plotted as mean ± SEM (n = 3).(C) FACS analysis of cell-cycle progression in control and MFAP1-depleted HeLa cells after G1 synchronization by double-thymidine block. Samples were collected at the indicated times (hours) after release and processed for flow cytometry. G1, S, and G2 cell populations were distinguished based on their DNA content and replication activity as in (B). Data are plotted as mean ± SEM (n = 3). The percentages of cells in G1, S, and G2 phases are depicted (B and C).(D) Analysis of apoptosis in siC- and siMFAP1-transfected HeLa cells as determined by FACS analysis of cells displaying subG1-DNA content. Data are plotted as mean ± SEM (n = 4).^∗∗^p \< 0.01 (Student's t test) (B and D).

MFAP1 Depletion Impairs Gene Expression and Alternative Splicing {#sec2.4}
----------------------------------------------------------------

Next, we wondered whether the effect of MFAP1 depletion on genome integrity could be related with a differential role on gene expression in comparison with THO-depleted cells. We analyzed the genome-wide transcription and alternative splicing profiles of control and MFAP1-depleted cells, using the Human Transcriptome Array (HTA) 2.0 from Affymetrix. Microarray analyses were performed with three different biological replicates of HeLa cells transfected with siC and siMFAP1 for 72 h. From a total of 67,528 genes analyzed, gene expression analysis identified 904 differentially expressed genes (p \< 0.05 and \|linear fold change\| \> 1.5), of which 359 (39.7%) were downregulated and 545 (60.3%) were upregulated in siMFAP1 cells ([Figure 5](#fig5){ref-type="fig"}A; [Table S2](#mmc2){ref-type="supplementary-material"}). Most downregulated transcripts were mRNAs (49%) or non-coding RNA (ncRNAs; 36.2%), whereas a majority of upregulated transcripts belonged to the category of U snRNAs (40%) ([Figure 5](#fig5){ref-type="fig"}B; [Table S2](#mmc2){ref-type="supplementary-material"}). Upregulation of U snRNAs, which are part of the spliceosome and participate in splicing, is consistent with a putative role of MFAP1 in pre-mRNA splicing ([@bib4]). Gene ontology (GO) analyses reveal a high variety of biological processes enriched (p \< 0.05 and fold enrichment \> 1.5 times), such as those related to chromatin, gene silencing, apoptosis, DNA repair, and cellular response to stress and DNA damage ([Table S2](#mmc2){ref-type="supplementary-material"}). Genes involved in different stress responses were altered in siMFAP1 cells. Thus, the transcriptome analysis reveals an increase of p21 expression, involved in the p53-dependent G1 arrest, and MDM2, an E3 ubiquitin ligase that regulates p53, among others ([Table S2](#mmc2){ref-type="supplementary-material"}). Transcript levels of some DDR genes were also altered, such as FANCD2, a component of the Fanconi anemia pathway, and DRAM2, a DNA damage-regulated autophagy modulator ([Table S2](#mmc2){ref-type="supplementary-material"}). Western blots also showed a reduction at the protein level in some of the cases ([Figure S3](#mmc1){ref-type="supplementary-material"}A). Altogether, our results suggest that siMFAP1 affects genes responding to stress and DNA damage, among others.Figure 5HTA 2.0 Gene Expression and Splicing Analysis of MFAP1-Depleted Cells(A) Volcano plot of differential gene expression in MFAP1-depleted HeLa cells compared with siC control cells (n = 3). Green dots correspond to downregulated genes, and red dots correspond to upregulated genes (p \< 0.05 and \|linear fold change\| \> 1.5) (see [Table S2](#mmc2){ref-type="supplementary-material"}).(B) Pie charts showing the distribution of the different downregulated (left) and upregulated (right) transcript types. Transcript numbers in each group are also indicated.(C) Pie chart showing the alternative splicing-type distribution in siMFAP1-transfected HeLa cells. See also [Figure S3](#mmc1){ref-type="supplementary-material"}B. Alternative splicing events (AS events) in siMFAP1 cells with p \< 0.01 and \|splicing index\| \> 2 were considered (n = 3). This distribution was calculated from those alternative splicing events with annotations for the type of alternative splicing in the Ensembl database (n = 2491). See also [Table S4](#mmc4){ref-type="supplementary-material"}.(D) Plot showing the levels of gene expression of the corresponding gene against the splicing indexes (SIs) \< −2 or \>2 (p \< 0.01) of probe sets within siMFAP1 cells.(E) Table showing the top 10 most significant gene ontology (GO) biological processes affected.BF, background frequency; CF, cluster frequency; FE, fold enrichment. See also [Table S6](#mmc6){ref-type="supplementary-material"}.

Given the interaction between MFAP1 and THOC1, we also included siTHOC1 cells in our analysis. Only a few genes were deregulated (84 out of 67,528), and no biological process was significantly enriched in siTHOC1 cells ([Table S3](#mmc3){ref-type="supplementary-material"}).

Next, we analyzed whether the splicing patterns were altered in siMFAP1 cells. For that, the splicing index (SI) was used to detect splicing changes between MFAP1-depleted cells and siC control cells. The SI represents the change in probe-set inclusion normalized to the change of gene-level expression. We identified 5,490 alternative splicing events that belonged to 3,689 genes in siMFAP1 cells (\|splicing index\| ≥ 2 and p \< 0.01) ([Table S4](#mmc4){ref-type="supplementary-material"}). A lower effect in gene splicing was observed after THOC1 depletion (1,022 alternative splicing events corresponding to 921 genes) ([Table S5](#mmc5){ref-type="supplementary-material"}). Comparative analysis of data reveals only a minor overlap of genes with significant changes in splicing between siTHOC1 and siMFAP1 cells (299 genes out 3,390 genes with different alternative splicing in siMFAP1 cells) ([Figure S3](#mmc1){ref-type="supplementary-material"}B).

Taken together, these data suggest that MFAP1 depletion has a high impact on splicing, but not THOC1. Further analysis of the transcriptome of siMFAP1 cells revealed that MFAP1 depletion caused different types of alternative splicing being the skipping or inclusion of a particular exon (cassette exon), the most common type (49%), whereas no case of mutually exclusive exons was found ([Figure 5](#fig5){ref-type="fig"}C; [Figure S3](#mmc1){ref-type="supplementary-material"}C). Alterations in splicing patterns in siMFAP1 cells seem not to be due to changes in transcription, because no relationship was found between gene expression levels and SIs ([Figure 5](#fig5){ref-type="fig"}D). To assay whether MFAP1 depletion impaired splicing, we performed qRT-PCR of the *β-actin* gene and measured the efficiency of splicing as the ratio of unspliced versus spliced RNAs for different introns. A lower splicing efficiency was observed in siMFAP1 cells ([Figure S3](#mmc1){ref-type="supplementary-material"}D), supporting that MFAP1 functions in splicing.

Interestingly, even though a varied number of biological processes are covered by the differentially spliced genes in siMFAP1 cells, a large proportion of the genes were involved in cell-cycle regulation, DNA damage response (DDR), DNA repair, nuclear export, or chromatin organization and modification ([Figure 5](#fig5){ref-type="fig"}E; [Table S6](#mmc6){ref-type="supplementary-material"}) (p \< 0.001 for a fold enrichment \> 1.5). These data indicate that MFAP1 has a broad effect on splicing, and that the different phenotypes of siMFAP1 cells, including genome instability, cell-cycle proliferation defect, or apoptosis, could be the consequence of the altered expression and splicing profile of a broad range of genes, rather than a subset of genes, as it has been shown for other splicing factors ([@bib76], [@bib74]).

A Conserved Role for the Yeast Orthologous *SPP381* Gene {#sec2.5}
--------------------------------------------------------

MFAP1 is conserved in the eukaryotes analyzed ([@bib4], [@bib43]); so to identify the putative MFAP1 ortholog in *Saccharomyces cerevisiae*, the most appropriate model organism to validate our study in another eukaryote, we performed an *in silico* search based on sequence comparison. Thus, we identified Spp381, a protein that displays a 13.3% amino acid identity and 22.3% similarity with human MFAP1, as determined by BLAST analysis of *S. cerevisiae* proteome using as a query Saf3, the putative ortholog in the fission yeast *Schizosaccharomyces pombe* ([@bib53]) ([Figure S4](#mmc1){ref-type="supplementary-material"}A). Indeed, recent bioinformatics and biochemical analysis have shown that MFAP1 and Spp381 proteins share characteristic structural features, favoring the conclusion that these genes are conserved from yeast to humans ([@bib72], [@bib73]). Interestingly, *SPP381* was identified as a suppressor of a mutant of the splicing factor *PRP38* ([@bib42]), consistent with the idea that *SPP381* could also be involved in splicing.

Consequently, we explored whether *SPP381* had any effect on genome instability in *S. cerevisiae*. For this, we assayed the sensitivity of *ssp381-ts* to different genotoxic agents such as UV radiation; the alkylating agent methylmethanesulfonate (MMS); hydroxyurea (HU), which inhibits replication; and Camptothecin (CPT), an inhibitor of DNA topoisomerase I ([Figure 6](#fig6){ref-type="fig"}A). *ssp381-ts* was highly sensitive to UV and HU, suggesting an accumulation of DNA damage. Next, we analyzed whether lack of a functional *SPP381* conferred an increase of spontaneous recombination as an indirect measure of DNA breaks, using the L and LYΔNS direct-repeat recombination systems based on direct repeats of a 600-bp region of the *LEU2* gene containing 31 bp and 3.7 kb of intervening sequence, respectively ([@bib50]). The *spp381-ts* mutant shows a 3.9- and 7.8-fold increase in the two systems, respectively ([Figure 6](#fig6){ref-type="fig"}B, left panel), suggesting that the longer regions being transcribed in LYΔNS versus L had little accumulation of DNA damage, in contrast with an expected transcription-dependent phenotype as previously shown for THO mutants ([@bib50]). To directly assay whether the hyperrecombination phenotype was transcription dependent, we analyzed recombination in the L-lacZ and GL-lacZ systems carrying the same 0.6-kb *leu2* direct repeats flanking the lacZ open reading frame (ORF), under the *LEU2* and *GAL1* promoter, respectively, under no transcription (GL-lacZ in 2% glucose) or active transcription (L-lacZ in 2% glucose). As can be seen in [Figure 6](#fig6){ref-type="fig"}B (right panel), a similar increase of recombination was observed in both systems in the *spp381* mutant. These results suggest that the hyperrecombination phenotype of *spp381* mutant is not associated with transcription. Consistent with the increased genomic instability, high levels of Rad52-YFP foci were detected in *SPP381*-deficient cells, both in the conditional mutant *spp381-ts* (BY4741 background) and in the null mutant *spp381Δ* (viable in the CEN.PK background) ([Figure 6](#fig6){ref-type="fig"}C). Importantly, such an increase in Rad52-YFP foci percentage was not suppressed by RNase H1 overexpression in any of the mutants, confirming that R-loops are not responsible for the genetic instability of *SPP381*-deficient cells ([Figure 6](#fig6){ref-type="fig"}C). Altogether, our data suggest that lack of MFAP1 and Spp381 proteins confers a similar genome-instability phenotype that is not co-transcriptional or R-loop dependent, implying an evolutionarily conserved role in the maintenance of genome integrity of MFAP1 in eukaryotes that is not related with that of THO.Figure 6Genome Instability and Expression Defects Caused by Lack of *SPP381* in *S. cerevisiae*(A) Analysis of sensitivity to different genotoxic agents (UV, methylmethanesulfonate \[MMS\], hydroxyurea \[HU\], and camptothecin \[CPT\]) of wild-type (WT; YDR007W) and *spp381-ts* (YPH2622-2D-4B) strains. Ten-fold serial dilutions of *spp381-ts* and WT cells were plated on minimal complete medium (SC). Photographs were taken after 3 days of growth at 30°C and 37°C (n = 3).(B) Recombination analysis of WT (Y07202) and *spp381-ts* (YPH2622-2D-4B) cells carrying L and LYΔNS plasmid system (left panel), and cells carrying the GL-*lac*Z system under the control of the inducible *GAL* promoter in glucose (OFF), or the L-*lac*Z system expressed under the control of the constitutive *LEU2* promoter (ON) (right panel).(C) Percentage of spontaneous Rad52-YFP foci formation in WT and *spp381-ts* strains (BY4741 background) (left panel) with or without RNase H1 (RNH1) overexpression from the pCM184-RNH1 plasmid. Percentage of spontaneous Rad52-YFP foci formation in WT (CEN.PK) and *spp381Δ* (CEN.RO20-3A) strains with or without RNase H1 (RNH1) overexpression from the pCM189-RNH1 plasmid (right panel). Mean ± SEM of three independent experiments are depicted (B and C). A scheme of recombination system (B) or Rad52-YFP plasmid (C) is shown on top of each panel.(D) Volcano plot of differential gene expression as determined by RNA-seq in *spp381-ts* cells compared with WT control cells after temperature shift (n = 3). Green dots correspond to downregulated genes, and red dots correspond to upregulated genes (p \< 0.05 and \|linear fold change\| \> 1.5) (see [Table S7](#mmc7){ref-type="supplementary-material"}).(E) Distribution of intron-containing genes versus the relative intron signal of the *spp381-ts* with respect to wild type. The data for each intron were normalized by host gene expression and pairwise between WT and spp381-ts as described in the [STAR Methods](#sec4){ref-type="sec"} (Transcription analysis by RNA-seq) ([Table S7](#mmc7){ref-type="supplementary-material"}). Data are adjusted to a Gaussian curve plotted in red (R^2^ = 0.59). Dashed lines in blue represent the threshold of significant fold-changes of intron signals (\>1.5 and p value \< 0.05).(F) Visualization of RNA-seq coverage across different regions of *Saccharomyces cerevisiae*. Zoomed view of *RPL19B* gene, *MMS2* gene, and *UBC4* gene. The y axis shows the number of reads. Genes and other features are represented according to the *Saccharomyces* Genome Database (SGD).^∗∗∗∗^p \< 0.0001, ^∗∗∗^p \< 0.001, ^∗∗^p \< 0.01, ^∗^p \< 0.05 (Student's t test) (B and C).

We wondered whether *SPP381* could have a role in gene expression and splicing similar to its human homolog MFAP1. For this purpose, we did RNA-seq of *spp381-ts* and wild-type cells after 1 h of shift from permissive (26°C) to restrictive temperature (37°C). RNA-seq analysis revealed that from a total of 6,692 genes, mRNAs from 500 genes were significantly increased and mRNAs from 378 genes were decreased in *spp381-ts* (\|linear fold change\| \> 1.5 and p value \< 0.05) ([Table S7](#mmc7){ref-type="supplementary-material"}; [Figure 6](#fig6){ref-type="fig"}D). The functional classes of genes related with metabolic process and with the response to different stresses were enriched in upregulated transcripts ([Table S7](#mmc7){ref-type="supplementary-material"}). Classes including endoplasmic reticulum, protein glycosylation, ribosome, microtubules, and cell-cycle genes, among others, were overrepresented in downregulated transcripts. Although DDR genes were not found as an enriched category, RNA levels of some DDR proteins were downregulated (Alk1, Alk2, and Cdc5 kinases, Rtt109 histone acetyltransferase, and Rtt107), in agreement with the sensitivity to genotoxic stress ([Table S7](#mmc7){ref-type="supplementary-material"}).

Finally, we wondered whether other mRNA biogenesis processes such as mRNA export were also affected. For this purpose, oligo dT-FISH experiments were performed in *spp381-ts* cells, using *mex67-ts* as an export mutant-positive control. No retention of bulk polyA^+^ mRNA was observed in *spp381-ts* cells ([Figure S4](#mmc1){ref-type="supplementary-material"}B). This is consistent with the result that an RNA export defect per se does not cause genome instability ([@bib21]). Next, we analyzed the impact of *spp381-ts* in splicing by measuring the intron signal in the mutant versus the wild-type from the RNA-seq reads of the intron-containing genes. Significant differences (\|linear fold change\| \> 1.5 and p value \< 0.05) were found in 54 out of 297 RNA polymerase II intron-containing genes, consistent with a global defect in splicing ([Table S7](#mmc7){ref-type="supplementary-material"}; [Figure 6](#fig6){ref-type="fig"}E) and with the identification of *SPP381* in a screening of splicing mutants in yeast ([@bib17]). Interestingly, despite that in *S. cerevisiae* only a few DDR genes contain introns, an effect in splicing of some of them (*MMS2*, *REC114*, *UBC4*, and *DMC1*) was found, apart from ribosomal protein-coding genes ([Table S7](#mmc7){ref-type="supplementary-material"}; [Figure 6](#fig6){ref-type="fig"}F). Altogether, our data support a conserved role of *SPP381*/MFAP1 in gene expression and splicing.

Discussion {#sec3}
==========

We have found an interaction between THOC1, a subunit of the conserved THO complex, and MFAP1, a spliceosome-associated protein whose depletion alters gene expression and splicing, and affects genome integrity. This interaction highlights the key role of THO in the connection of transcription with mRNA metabolism. We show evidence that MFAP1 is a conserved spliceosome component with a broad role in splicing ([Figures 1](#fig1){ref-type="fig"} and [5](#fig5){ref-type="fig"}) and whose depletion affects cell cycle and proliferation in human cells ([Figure 4](#fig4){ref-type="fig"}). Importantly, functional analysis in human and yeast cells shows that lack of MFAP1/Spp381 confers a genome instability that, in contrast with THO mutants, is not mediated by R-loops ([Figures 2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"}, and [6](#fig6){ref-type="fig"}). Our results suggest that MFAP1 contributes to genome integrity by regulating gene expression and splicing, including that of genes involved in DDR. It is likely that the effect of the yeast Spp381 ortholog in genome instability is also due to its impact on gene expression, provided that many yeast genes do not contain introns. Indeed, we show an RNA-seq analysis of the *spp381-ts* mutant that supports a wider role of *SPP381* in gene expression and mRNA splicing ([Figures 6](#fig6){ref-type="fig"}D--6F; [Table S7](#mmc7){ref-type="supplementary-material"}).

MFAP1 was initially identified as a component of the extracellular matrix ([@bib29], [@bib78]), but later was found in proteomic analysis of the spliceosome bound to the B complex, an intermediate complex in spliceosome assembly ([@bib26]). Here we show that MFAP1 interacts with SF3B1, a core spliceosome protein ([Figures 1](#fig1){ref-type="fig"}C and 1D), and is located at nuclear splicing speckles in human cells ([Figure 1](#fig1){ref-type="fig"}E). Altogether our results support that MFAP1 associates with the spliceosome in human cells. Consistently, hMFAP1 has been recently characterized as a B complex-associated spliceosome protein, as determined by biochemical and structural data ([@bib72], [@bib73]). Because the B complex carries out the first *trans*-esterification reaction of a splicing event, it is possible that some B complex-specific components have a role in alternative splicing. Indeed, we provide evidence that MFAP1 is a spliceosome-associated factor that affects both transcription and splicing, as determined by qRT-PCR of pre-mRNA ([Figure S3](#mmc1){ref-type="supplementary-material"}D) and transcriptome analysis of siMFAP1 cells ([Figure 5](#fig5){ref-type="fig"}; [Tables S2](#mmc2){ref-type="supplementary-material"}, [S4](#mmc4){ref-type="supplementary-material"}, and [S6](#mmc6){ref-type="supplementary-material"}). This may explain the varied number of phenotypes of MFAP1-depleted cells in cell proliferation ([Figure 4](#fig4){ref-type="fig"}), cell-cycle regulation ([@bib4], [@bib37]), or sister chromatid cohesion, in this latter case via the control of splicing of CDC5A ([@bib65]). Our transcriptome analysis indeed reveals alternative splicing alterations of a broad number of genes, which are enriched in those encoding factors involved in cell-cycle regulation, cellular response to DNA damage, or DNA repair among de-regulated spliced genes ([Figure 5](#fig5){ref-type="fig"}E; [Table S6](#mmc6){ref-type="supplementary-material"}). This can explain the pleiotropic effects of MFAP1 depletion on cell proliferation, apoptosis, and genome instability ([Figures 2](#fig2){ref-type="fig"} and [4](#fig4){ref-type="fig"}).

Our data suggest that MFAP1 has a broad effect on gene expression and splicing, being unlikely that only a subset of splicing events requires MFAP1. In contrast, a different scenario has been proposed for other splicing factors, for which a link between gene expression and changes in splicing of specific genes involved in genome instability has been described ([@bib76], [@bib51], [@bib74]). Thus, mutations of SF3B1 have been associated with alterations in the DDR in cancer cells ([@bib76]), and mRNA processing factors THRAP3 and BCLAF1 have been shown to play a role in the selective mRNA splicing and export of transcripts of DDR proteins. Interestingly, a recent study has reported a potential control of gene expression by spliceosome components including MFAP1 ([@bib47]).

THO/TREX subunits were identified in proteomic analysis as factors associated with the spliceosome ([@bib52], [@bib81]), and some of them (THOC1, THOC2, UAP56, and ALY) were found to colocalize with splicing factors at nuclear speckle domains ([@bib22], [@bib45], [@bib80]). In addition, ALY and UAP56 proteins have been shown to be necessary for efficient export of spliced mRNA from the nuclear speckles to the cytoplasm ([@bib15]). THOC1 interaction with MFAP1 strengthens the conclusions of other studies showing a relationship between THO/TREX and the splicing machinery ([@bib11], [@bib12], [@bib31], [@bib45]), which may explain why a subset of genes shows similar splicing alterations in siMFAP1 and siTHOC1 cells ([Figure S3](#mmc1){ref-type="supplementary-material"}B). In any case, our study indicates that THOC1 recruitment to active genes is not dependent on MFAP1 or the SF3B1 splicing factor ([Figure S1](#mmc1){ref-type="supplementary-material"}D).

Several RNA binding, heterogeneous nuclear ribonucleoproteins (hnRNPs) and RNA processing proteins, among them splicing factors, have been identified in different global screenings in yeast and humans as factors involved in the maintenance of genome instability ([@bib10], [@bib48], [@bib64]). A link between splicing and R-loop-mediated genome instability was suggested after a genome-wide screening revealing that knockdown of a number of splicing factors lead to an increase in DNA damage, as determined by γH2AX foci, which in some cases was partially suppressed by RNase H overexpression ([@bib48]). It has also been proposed that blocked transcription after DNA damage promotes selective chromatin displacement of late-stage spliceosomes, thus favoring R-loop formation, even though it is unclear how this would occur ([@bib69]). However, lack of MFAP1 in human cells compromises genome stability associated with an increase in DNA breaks and anaphase bridges, but this is not associated with transcription or R-loops ([Figures 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}). Similar phenotypes are observed in yeast *spp381* mutants ([Figure 6](#fig6){ref-type="fig"}). The data indicate that the role of MFAP1 in the maintenance of genome is conserved in eukaryotes and not related with R-loop prevention, arguing that splicing by itself has no direct protective role on genome integrity, consistent with the observation that different splicing-related factors have distinct effects in the DDR ([@bib58]). Some examples have been provided on a putative indirect effect of splicing mutations in genome integrity in yeast ([@bib66], [@bib14]). Moreover, it has just been reported that downregulation of the human splicing factor SLU7 is associated with an increase in R-loops and loss of sister chromatid cohesion, but these effects could be caused by the regulatory role of SLU7 in the expression of splicing factors such as SRSF3 and SRSF1 and the protein soronin, which is involved in sister chromatid cohesion ([@bib33]). Indeed, a cytological screen of RNA processing factors and chromatin modification mutants in yeast has shown that several splicing factors do not affect R-loops or R-loop-mediated genome instability ([@bib10]). Altogether, these results strengthen the conclusion that only a subset of RNA binding factors, such as, for instance, THO/TREX and SRSF1, has a direct role in preventing R-loop accumulation that compromises genome integrity ([Figure 7](#fig7){ref-type="fig"}).Figure 7A Model to Explain the Differential Role of RNA Processing Factors in Genome IntegrityAmong the many mRNP biogenesis and processing factors, specific RNA-binding factors, such as THO/TREX, would actively contribute to prevent co-transcriptional R-loop formation, thus playing a direct role in the prevention of genome instability, whereas other factors, such as MFAP1 and likely others, would play an indirect role on genome integrity independent of transcription and R-loops, resulting from their impact on the expression and/or splicing of genes directly controlling genome integrity.

In summary, the spliceosome-associated protein MFAP1 is a partner of THOC1, with a broad effect in alternative splicing. Despite the fact that MFAP1 contributes to the maintenance of genome integrity, this is not functionally related to THO but rather an indirect consequence of the effect of MFAP1 depletion on alternative splicing and gene expression of a number of genes, including DDR genes, a phenomenon that may explain the effect of numerous mutations in splicing factors on genome integrity.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Mouse monoclonal anti-THOC1AbcamCat\# ab487, RRID:[AB_304696](nif-antibody:AB_304696){#intref0010}Rabbit polyclonal anti-MFAP1AbcamCat\# ab175508Mouse monoclonal anti-GFPRocheCat\# 11814460001, RRID:[AB_390913](nif-antibody:AB_390913){#intref0015}Mouse monoclonal anti-SC35AbcamCat\# ab11826,RRID:[AB_298608](nif-antibody:AB_298608){#intref0020}Mouse monoclonal anti-γH2AXMilliporeCat\# 05-636, RRID:[AB_309864](nif-antibody:AB_309864){#intref0025}Rabbit monoclonal anti-p21AbcamCat\# ab109520, RRID:[AB_10860537](nif-antibody:AB_10860537){#intref0030}Mouse monoclonal anti-FANCD2Santa CruzCat\# sc-20022, RRID:[AB_2278211](nif-antibody:AB_2278211){#intref0035}Mouse monoclonal anti-vinculinSigma-AldrichCat\# V9264, RRID:[AB_10603627](nif-antibody:AB_10603627){#intref0040}Mouse monoclonal anti-SF3B1Antibodies onlineCat\# ABIN1449241Rabbit polyclonal anti-beta-actinAbcamCat\# ab8227, RRID:[AB_2305186](nif-antibody:AB_2305186){#intref0045}Alexa fluor 594 RabbitThermofisherCat\# A21201, RRID:[AB_2535787](nif-antibody:AB_2535787){#intref0050}Alexa fluor 488 MouseThermofisherCat\# A21200, RRID:[AB_2535786](nif-antibody:AB_2535786){#intref0055}Anti-rabbit IgG peroxidase antibody produced in goatSigmaCat\# A6154, RRID:[AB_258284](nif-antibody:AB_258284){#intref0060}Anti-mouse IgG peroxidase antibody produced in goatSigmaCat\# A4416, RRID:[AB_258167](nif-antibody:AB_258167){#intref0065}**Chemicals, Peptides, and Recombinant Proteins**CordycepinSigmaCat\# C3394methylmethanesulfonate (MMS)FlukaCat\# 64294HydroxyureaUSBiologicalCat\# C11082252CamptothecinSigmaCat\# C9911NocodazoleSigmaCat\# 487928ThymidineSigmaCat\# T9250**Critical Commercial Assays**Duo-link *in situ* Red started Kit (mouse-rabbit). Proximity ligation assaySigmaCat\# DUO92101Comet assay KitTrevigenCat\# 4250-050-KGeneChip Human Transcriptome array 2.0 (HTA 2.0)ThermofisherCat\# 902162TruSeq® Stranded mRNA Library prep kitIlluminaCat\# 20020594**Deposited Data**Gene expression and alternative splicing profile of MFAP1- and THOC1-depleted human cellsGene Expression Omnibus database <https://www.ncbi.nlm.nih.gov/geo/>accession number GEO: GSE119412Transcriptome analysis by RNA-Seq of spp381-ts mutantGene Expression Omnibus database <https://www.ncbi.nlm.nih.gov/geo/>accession number GEO: GSE128010**Experimental Models: Cell Lines**HeLaECACCCat\# 93021013HEK293TATCCCat\# CRL-11268**Experimental Models: Organisms/Strains***Saccharomyces cerevisiae:* Strain background: BY4741 *MATa can1Δ::MFA1*pr-*HIS3*::*LEU2 his3Δ1 met15Δ0 spp381-ts::URA3*[@bib6]YPH2622*Saccharomyces cerevisiae:* Strain background: BY4741 *MATα his3Δ1 leu2Δ0 trp1Δ::KanMX4 spp381 ts::URA3*This study(YPH2622-2D-4B) This study*Saccharomyces cerevisiae:* Strain background: BY4741 *MATa; ura3Δ0; leu2Δ0; his3Δ1; met15Δ0; YDR007w::kanMX4*EuroscarfY07202*Saccharomyces cerevisiae:* Strain background: CEN.PK *MATa his3Δ1 leu2-3,112 ura3-52 trp1-289 MAL2 8c SUC2*EuroscarfCEN.PK2*Saccharomyces cerevisiae:* Strain background: CEN.PK *MATα his3Δ1 leu2-3,112 ura3-52 trp1 289 spp381Δ::LEU2*EuroscarfCEN.RO20-3A*Saccharomyces cerevisiae:* Strain background: W303-1A *MATa leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15 mex67-5*[@bib34]WMC1-1A**Oligonucleotides**siRNA and DNA oligonucleotides are listed in [Table S1](#mmc1){ref-type="supplementary-material"}N/AN/AoligodT-Cy3 probesSigma-AldrichN/A**Recombinant DNA**pEGFP-C2ClontechCat\# 6083-1pEGFP-MFAP1This studyN/ApcDNA3AdgeneN/ApcDNA3-RNaseH1([@bib67])N/ApRS314L([@bib50])N/ApRS314-LYΔNS([@bib50])N/ApRS314L-lacZ([@bib46], [@bib49])N/ApRS314GL-lacZ([@bib46], [@bib49])N/ApCM184-RNH1([@bib56])N/ApCM189-RNH1([@bib9])N/ApWJ1344([@bib41])N/A**Software and Algorithms**Adophe PhotoshopAdobeN/APRISM softwareGraphpadN/ALeica DM6000 microscopeLeicaN/ALeica DFC365FX cameraLeicaN/AMetaMorph v7.5.1.0Molecular ProbesN/AComet-score (version 1.5) software/ TriTek CometScore Professional (version 1.0.1.36) softwareTriTek CorporationN/A

Lead Contact and Materials Availability {#sec4.2}
---------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Andrés Aguilera (<aguilo@us.es>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Cell culture, siRNA and Plasmid Transfection {#sec4.3.1}

HeLa and HEK293T cells were cultured in Dulbecco's modified Eagle's medium (DMEM; GIBCO, Thermo Scientific, Waltham, MA) supplemented with 10% heat-inactivated fetal bovine serum at 37°C (5% CO2).

Yeast strains and plasmid used in this study are listed in [Key Resources Table](#sec4.1){ref-type="sec"}. All yeast strains were grown at 30°C, except for RNA Seq analysis, in which wild-type and *spp381-ts* cells were grown in YPAD media at mid-log phase at 26°C. After 1h of temperature shift from 26°C to 37°C cells were collected for RNA extraction.

Method Details {#sec4.4}
--------------

### siRNAs, plasmids and transfections {#sec4.4.1}

Transient transfection of siRNA was performed using DharmaFECT 1 (Dharmacon) according to the manufacturer's instructions. siRNA duplexes were obtained from Dharmacon ([Table S1](#mmc1){ref-type="supplementary-material"}). Fugene (Promega, Madison, WI, USA) was used for plasmid transfection. Assays were performed 72 h after siRNA transfection and 24 h after plasmid transfection.

Plasmids used to transfect cells are listed in [Key Resources Table](#sec4.1){ref-type="sec"}. pEGFP-MFAP1, contains the full-length human MFAP1 cDNA (from IMAGE clone 6200464, LifeSciences) cloned into pEGFP-C2 fused to EGFP; pcDNA3-RNaseH1, contains the full-length RNase H1 cloned into pcDNA3 ([@bib67]).

### Co-immunoprecipitation (coIP) {#sec4.4.2}

For co-immunoprecipitation assays, whole-cell extracts from a 10 cm Petri dish of HEK293T cells at 80% confluence were used and coIPs were performed as described ([@bib54]). When it is indicated, HEK293T cells were transfected with pEGFP-C2 or pEGFP-MFAP1 plasmids for 24 h. Briefly, cells were lysed in lysis buffer (10 mM Tris--HCl pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 0.5% (vol/vol) NP-40, 1 mm PMSF, and protease inhibitor cocktail) for 30 min on ice and the lysate was centrifuged for 15 min at 12,000 g at 4°C. 1:10 of cell extract was used for the input. Then, the lysate was diluted with dilution buffer (10 mM Tris--HCl pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 1 mM PMSF, and protease inhibitor cocktail) to obtain a 0.25% (vol/vol) final concentration of NP-40. For the immunoprecipitation, protein extract was incubated for 2 h at 4°C with 50 μl of Dynabeads Protein A (Invitrogen), previously conjugated with the specific antibody, or 40 μl of magnetic anti-GFP beads (GFP-trap, Chromotek). Beads were then washed twice with PBS and three times with dilution buffer with 0.2% NP-40. Finally, the precipitate was eluted by boiling the beads for 10 min in 2 × Laemmli loading buffer and analyzed by western blot. Incubation of one sample with IgG or protein extract from cells transfected with pEGFP-C2 were use as control.

### Chromatin immunoprecipitation (ChIP) {#sec4.4.3}

HeLa cells (5 × 10^6^) plated on 10-cm Petri dishes were crosslinked for 10 min with 1% formaldehyde and processed for ChIP as described ([@bib54]).

Cells were resuspended in 2.5 mL of cell lysis buffer (5 mM PIPES pH 8, 85 mM KCl, 0.5% NP-40, 1 mM PMSF, and protease inhibitor cocktail). The lysate was then centrifuged and resuspended in 1 mL of nuclei lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris--HCl pH 8, 1 mM PMSF, and protease inhibitor cocktail). Chromatin fragmentation was performed on ice-cold water bath with fifteen pulses of 30 s on and 30 s off on the maximum intensity setting in Bioruptor (Diagenode). 1300 μl containing 25 μg of chromatin diluted with IP buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris--HCl pH 8, 167 mM NaCl) were used for input (100 μl) and immunoprecipitation (1200 μl).Chromatin was incubated overnight at 4°C with 7.5 μg of MFAP1 or THOC1 specific antibodies or IgG to calculate the background signal. After incubation with 30 μl of Dynabeads Protein G (Invitrogen) for 2 h at 4°C, beads were washed once with wash buffer 1 (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris--HCl pH 8, 150 mM NaCl), once with wash buffer 2 (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris--HCl pH 8, 500 mM NaCl), once with wash buffer 3 (0.25 M LiCl, 1% NP-40, 1% sodium deoxycholate, 1 mM EDTA, 10 mM Tris--HCl pH 8), and twice with 1 × TE. The precipitated was eluted in TE-1% SDS for 20 min at 65°C. Input and immunoprecipitate were then un-crosslinked overnight at 65°C in TE-1% SDS. After proteinase K treatment for 1 h at 45°C, NucleoSpin Gel and PCR Clean-up kit (Macherey- Nagel) was used to isolate the DNA.

The amount of DNA was determined by real-time qPCR. DNA amount expressed in arbitrary units (A. U.) was calculated based on a standard DNA curve. Signal values in the different regions were plotted as the ratio between the immunoprecipitated DNA subtracting the background signal (IP) and the total amount of DNA (input) of each region. Signal values in the different regions were plotted as the ratio between the DNA amount immunoprecipitated subtracting the background signal (IP) and the total amount of DNA (input) of each region. Primers used for real-time quantitative PCR (qPCR) are described in [Table S1](#mmc1){ref-type="supplementary-material"}.

### Immunofluorescence {#sec4.4.4}

Cells were cultured on glass coverslips, pre-permeabilized with cold 0.1% triton in PBS on ice for 1 min and then fixed in 2% formaldehyde in PBS for 20 min at RT and permeabilized with 70% ethanol for 5 min at −20°C, 5 min at 4°C, and washed twice in PBS. PBS-3% BSA was used as blocking solution and for antibodies dilution. The following antibody dilutions were used: anti-MFAP1 (1:250), anti-SC35 (1:500), anti-THOC1 (1:250), anti-SF3B1 (1:200), and secondary antibodies conjugated with Alexa Fluor (1:500) ([Key Resources Table](#sec4.1){ref-type="sec"}). DNA was stained with DAPI. Images were captured at 63 × magnification. For γH2AX foci, measurements were analyzed and processed with the MetaMorph v7.5.1.0 (Molecular Probes) image analysis software.

### Proximity ligation assay (PLA) {#sec4.4.5}

The proximity ligation assay was performed as described ([@bib8], [@bib61]) with reagents from Duolink *In Situ* Red Starter Kit (Sigma) in accordance with the manufacturer's instructions. Cells were cultured on glass coverslips pre-permeabilized with cold 0.1% Triton in PBS on ice for 1 min, fixed in 2% formaldehyde in PBS for 20 min and permeabilized with 70% ethanol for 5 min at 20°C. Coverslips were blocked with PBS-3% BSA for 1 h at RT, incubated with primary antibodies diluted in PBS-3%BSA for 2 h at RT, washed three times in PBS for 5 min and incubated with PLA probes for 1 h at 37°C. After two washed in wash buffer A for 5 min, ligation reaction was performed for 30 min at 37°C. Then, cells were washed twice in wash buffer A, incubated with the amplification reaction for 100 min at 37°C in darkness, washed twice in buffer B for 10 min and once in 0.01X wash buffer B for 1 min. Finally, coverslips were dried in darkness, mounted with mounting medium with DAPI. For negative controls, everything was performed identically, except that only one of the primary antibodies was added. Images were captured at 63 × magnification.

### Single-cell electrophoresis {#sec4.4.6}

Alkaline and neutral single-cell electrophoresis or comet assays were performed as described ([@bib16], [@bib54]) using a commercial kit (Trevigen, Gaithersburg, MD, USA) following the manufacturer's protocol. In brief, cells were collected using accutase, washed and resuspended in ice cold 1X PBS, combined with low melting agarose, immobilized on CometSlides (30 min at 4°C, until agarose is solidified). For alkaline single-cell electrophoresis, lysis was performed for 30 min at 4°C in lysis buffer. Then, DNA was unwound and denatured in freshly prepared alkaline unwinding solution pH˃13 (200 mM NaOH, 1 mM EDTA) for 30 min at RT and electrophoresis was performed in prechilled alkaline electrophoresis solution pH˃13 (200 mM NaOH, 1 mM EDTA) at 21 V for 30 min. Next, slides were immersed twice in dH~2~O for 5 min each, then in 70% ethanol for 5 min and dried at RT. DNA was stained with SYBR Green at 4°C for 5 min. For neutral single-cell electrophoresis, cells were lysed for 1 h at 4°C and immersed in prechilled 1X neutral electrophoresis buffer (0.1M Tris, 0.3M Sodium acetate, pH 9 adjusted with glacial acetic acid) for 30 min at 4°C. Electrophoresis was performed in prechilled 1X neutral electrophoresis buffer at 35 V for 15 min and then immersed in DNA precipitation solution for 30 min at RT. Finally, slides were immersed in 70% ethanol for 30 min at RT and dried. DNA was stained with SYBR Green at 4°C for 30 min. When it is indicated, 50 μM cordycepin was added to the culture 4 h before starting the experiment. Comet slides were stained with SYBR Green. Images were captured at 10 × magnification. Comet-score (version 1.5) software or TriTek CometScore Professional (version 1.0.1.36) software were used to analyze comet tail moments. At least 100 cells were scored in each experiment and the median of tail moments was calculated.

### Anaphase bridges and sister chromatin exchange (SCE) events assays {#sec4.4.7}

Analysis of anaphase bridges and SCE events were performed 72 h after siRNA transfection, as previously described ([@bib71]). To score anaphase bridges, HeLa cells were cultured on glass coverslips and transfected with siRNA for 72 h. In order to increase the proportion of cells in mitosis, cells were treated with 50 ng/ml nocodazol (Sigma) in complete medium for 4 h at 37°C, washed twice carefully in PBS and incubated for 1 h in 2 mL complete medium before to be harvested. Then, cells were fixed and permeabilized directly in the well adding 2 mL of 4% formaldehyde -- 0.5% Triton X-100 in PBS during 20 min at RT. After immersing the coverslips carefully in PBS vectashield mounting medium with DAPI was used for the mounting. The percentage of cells in anaphase with anaphase bridges was calculated. At least 100 anaphases from each experiment were analyzed. For SCE assay, 24 hours after siRNA transfection HeLa cells were incubated with 10 μM BrdU for 42 hours followed by 3 hours treatment with 0.1 μg/ml of KaryoMAX colcemid solution (Invitrogen). Cells were harvested by tripsinization, resuspended in 0.075 M KCl hypotonic solution 10 min at 37°C and fixed with Carnoy′s fixative (3:1 methanol:acetic acid, 3 changes). Cells were then dropped onto slides and baked overnight at 65°C. For the differential staining of sister chromatids, chromosome preparation were immersed in Hoechst solution (20 μg/ml) for 20 min, then exposed for 1 hour to UVA irradiation in 2X SSC (0.3 M NaCl, 0.03 M trisodium citrate, pH 7). and incubated in 2X SSC at 60°C for 20 min. Slides were stained with Giemsa (1:20) in buffer Weise pH 6.8 (Millipore). At least 20 metaphases from each experiment were analyzed. Metaphases were scored using a 100 × objective.

### Microscopy images acquisition and data analysis {#sec4.4.8}

A Leica DM6000 microscope equipped with a DFC390 camera (Leica) and the LAS AF software (Leica) were used for fluorescence microscopy images and data acquisition, respectively. Software used for image analysis are listed in [Key Resources Table](#sec4.1){ref-type="sec"}.

### Cell proliferation, cell cycle and apoptosis assays {#sec4.4.9}

Cell proliferation, cell cycle and apoptosis assays were performed as previously described ([@bib54]). For proliferation assays, after 48 h of siRNA transfection cells were detached using accutase, counted and plated in wells of 96-well plates (2000 cells/well) in a final volume of 100 μl. Once cells were attached on the plate (7 h later), the first quantification was performed and was considered the day 0. Cells were transfected again 3 days after first transfection with 2/5 of siRNA standard amount. For colorimetric determination of viable cell numbers the cell proliferation reagent WST-1 reagent (Roche) was used following the manufacture′s protocol. Cells were incubated with WST-1 reagents (10 μl/well) for 2 h at 37°C and 5% CO~2~ in darkness. After this incubation period, absorbance was measured at 450 nm with a reference wavelength of 690 nm. For this, the scanning multi-well spectrophotometer ELISA reader VARIOSKAN FLASH (Thermo) was used. The measured absorbance directly correlates to the number of viable cells. Measurements were performed each 24 hours. Absorbance values were normalized to the value at the day 0 and represented as arbitrary units (A.U.). For cell cycle and FACS analysis, HeLa cells were incubated with EdU (20 μM) for 20 min 72 h after siRNA transfection to allow EdU incorporation in replicating cells. Cells were harvested with accutase, washed with PBS and centrifuged (10000 rpm 10 s). Pellet was resuspended in 300 μL cold PBS and cells were fixed by adding 700 μL cold 96% ethanol drop by drop and incubated at least 1 h on ice. After centrifugation (10000 rpm) ethanol was removed and 800 μL of 0.5% Triton X-100 in PBS was added to the pellet, mixed by vortexing and incubated on ice for 15 min. Then, cells were centrifuged (10000 rpm), washed in 800 μL of 1% BSA, 0.5% Tween-20 in PBS and centrifuged again. Click-iT assay kit (Thermo Fisher Scientific) was used for EdU incorporation detection, using the manufacturer's protocol. For this, pellet was resuspended in 100 μL Click-iT reaction, incubated for 30 min at RT in darkness and washed three times in 800 μL of 1% BSA, 0.5% Tween-20 in PBS. For RNA degradation and DNA stain, cells were incubated with 700 μL of PBS with 7 μL RNase A 10 mg/ml and 5 μL of 7-Amino-Actinomycin D (7-AAD) at least for 30 min before being scored by FACS. G1, S and G2-phase cell were analyzed base on their DNA content and EdU signal by FACS. When it is indicated, cells were synchronized using a double thymidine block. For this, 24 h after siRNA transfection, cells were incubated with fresh medium containing 2 mM thymidine for 19 h. Then, cells were washed three times with PBS and were released in fresh complete medium for 7 h. Afterward, medium was replaced with fresh medium containing 2 mM thymidine and cells were incubated for 17--19 h. After three washed in PBS, cell were released in fresh complete medium and time points were collected. 20 min before collect the samples, cells were incubated with EdU (20 μM) for 20 min and processed as described above. To measure apoptotic cell population by analysis of sub-G1 DNA content, floating and adherent siRNA-depleted HeLa cells from two well of a 6-well plate were harvested, washed with cold PBS, centrifuged at 3500 rpm for 2 min and resuspended in 100 μL PBS. For fixation, 900 μL of cold 70% ethanol was added drop by drop during vortexing and cells were incubated at least 5 minutes at 4°C. Afterward, cells were centrifuged at 3500 rpm for 2 min, washed with 2 mL PBS, resuspended in 250 μL PBS and 250 μL of DNA extraction solution (0.2 M Na~2~HPO~4~, 4 mM Citric Acid, pH 7.8) was added. After incubation for 10 min at 37°C, cells were centrifuged and pellet was resuspended in 300 μL of PI/RNase A solution (100 μg/ml RNase A, 5 μg/ml Propidium Iodide in PBS) and incubated for 30 min in darkness. Quantitative analyses of different cell populations were carried out in a FACScan cytometer using the Cell Quest software (BD Biosciences). At least 5000 cells were scored by FACS and the percentage of cells in G1, S and G1-phase or cells with sub-G1 DNA content was calculated.

### mRNA quantification {#sec4.4.10}

Total RNA was extracted using RNeasy Mini Kit (QIAGEN) and cDNA was synthesized by reverse transcription using QuantiTect Reverse transcription (QIAGEN). Relative mRNA levels in human cells were determined using relative qPCRs. A 7500 Fast Real-Time PCR system (Applied Biosystems, Carlsbad, CA) was used to perform real-time qPCRs (qPCRs). mRNA expression values of MFAP1 gene was normalized to the expression of the HPRT housekeeping gene. Mean and SEM of relative signal values normalized with respect to the siC control are provided. Primers used in real-time qPCR for mRNA quantification are listed in [Table S1](#mmc1){ref-type="supplementary-material"}. The ratio of β-actin unspliced RNA (exon-intron primers) versus the spliced RNA (exon-exon primers) for different introns was analyzed by reverse transcription-quantitative PCR (RT-qPCR) in siC and siMFAP1 cells. Primers used are listed in [Table S1](#mmc1){ref-type="supplementary-material"}.

### Microarray analyses of gene expression and alternative splicing {#sec4.4.11}

Gene expression and alternative splicing microarray was performed using the Affymetrix platform GeneChip Human Transcriptome array 2.0 (HTA 2.0) ([Key Resources Table](#sec4.1){ref-type="sec"}) containing a median of 10 probes per exon or ncRNA and 4 probes per junction (\> 6.0 million distinct probes in total covering coding and non-coding transcript) . 70% of the probes on this array cover exons for coding transcripts, and the remaining 30% of probes on the array cover exon-exon junctions, splice junctions and non-coding transcripts.

Total RNA was isolated in triplicate from HeLa siRNA transfected cells for 72 h by using the RNeasy Mini Kit (QIAGEN). The purity and quality of isolated RNA was confirmed by 2100 Bioanalyzer (Agilent Technologies). 100 ng of total RNA from each sample was used for amplification and production of biotinylated sense-strand cDNA from the entire expressed genome according to the GeneChip® WT PLUS Reagent Kit User Manual (P/N 703147 Rev. 3). Labeled ssDNA was hybridized to the GeneChip HTA Arrays (GeneChipTM Human Transcriptome Array 2.0) and scanned using the GeneChip Scanner 3000 7G according to the manufacture's recommendations.

### Microarray data analysis {#sec4.4.12}

Data are available from the Gene Expression Omnibus database (accession number [GSE119412](ncbi-geo:GSE119412){#intref0085}) ([Key Resources Table](#sec4.1){ref-type="sec"}).

For each condition, microarray analysis was conducted in triplicate from three different biological replicates. Raw data were extracted from the scanned images and analyzed with the Affymetrix GeneChip Command Console® (AGCC) Software 2.0. Raw data were pre-processed and normalized using the SST (Signal Space transformation)-RMA (Robust Microarray Average) method ([@bib32]). Data were further processed using Transcriptome Analysis Console (TAC) Software 3.0 from Affymetrix, which performs a gene-level analysis or an alternative splicing analysis.

For gene expression analysis, genes showing expression changes with P value \< 0.05 (ANOVA) and a \|linear fold change\| \> 1.5 were considered significant.

For alternative splicing analysis, splicing index (SI) was calculated as follows:

SI = Log2 \[(Gene-set 1 Condition 1 /Gene 1 Condition 1 intensity)/(Gene-set 1 Condition Control Intensity/Gene1 Condition Control Intensity)\] Condition 1 refers to siMFAP1 or siTHOC1 depleted cells and Condition control to siC depleted cells.

Splicing changes were considered to be significant when a gene is expressed in both conditions, A PRS/Junction must be expressed in at least one condition, a gene must contain at least one PRS, \|Splicing Index (SI)\| was \> 2 and P value \< 0.01 (ANOVA).

### Gene set enrichment analysis {#sec4.4.13}

Gene Ontology (GO) analyses of enriched biological processes (BPs) or cellular component were performed using DAVID (Database for Annotation, Visualization and Integrated Discovery) bioinformatics resources 6.8 tool (<https://david-d.ncifcrf.gov/summary.jsp>). A P value \< 0.01 or P value \< 0.001 and fold enrichment \> 1.5 was established to consider GO terms as significantly enriched in gene expression (microarrays and RNA-seq) and alternative splicing analyses, and was indicated in each case.

### Transcription analysis by RNA-seq {#sec4.4.14}

Wild-type and spp381-ts cells were grown in YPAD media at mid-log phase at 26°C. After 1h of temperature shift from 26°C to 37°C cells were collected for RNA extraction. RNA was extracted with the RNeasyMini Kit (QIAGEN, Hilden, Germany) and treated with the RNase-Free DNase Set (QIAGEN) to remove any contaminating genomic DNA, according to the manufacturer's protocols. RNA samples were analyzed for quality with the RNA 6000 Nano assay on a 2100 Bioanalyzer (Agilent Technologies), and quantified with the Qubit RNA HS Assay (ThermoFisher Scientific).

RNA-Seq was performed by Genomics Core Facility of CABIMER. Sequencing libraries were performed from 150 ng RNA samples using the TruSeq® Stranded mRNA Library prep kit (Illumina) ([Key Resources Table](#sec4.1){ref-type="sec"}), and subsequently pooled and sequenced on Illumina NextSeq500 using 2 × 75-bp paired-end chemistry. Raw reads were filtered and trimmed with FASTQ toolkit 1.0.0 by BaseSpace Sequence Hub Illumina website and Fastq data were submitted to the Galaxy web platform for further analyses ([@bib1]). So, reads were mapped to the *S. cerevisiae* genome version sacCer3 with the HISAT2 v2.1.0 aligner ([@bib36]), and filtered for high quality mapping (MapQuality \> 30) using BAM tools ([@bib5]). Next, aligned reads were counted at gene and intron level by Feature Counts v1.6.2 ([@bib40]) and differential expression analyses were performed using limma Bioconductor package ([@bib38]). The differentially expressed genes (DEGs) were selected as those with q-value threshold \< 0.05 and a linear fold change value \> 1.5. To identify intron retention (IR) event, the data for each intron was normalized by host gene expression and pairwise comparised between wt and spp381-ts within limma pipeline. The cutoff for filtering IR event was p value \< 0.05 and fold-change value \> 1.5

Data are available from the Gene Expression Omnibus database (accession number [GSE128010](ncbi-geo:GSE128010){#intref0095}).

### Yeast strains and analysis of Rad52-foci and recombination frequencies {#sec4.4.15}

Yeast strains and plasmids used in this study are described in the [Key Resources Table](#sec4.1){ref-type="sec"}. YPH2622-2D-4B carries a termosensitive allele of SSP381 gene. This strain has a BY4741 genetic background and it was obtained by genetic crosses between YDR007W and YPH2622 strains. CEN.RO20-3A, is a deletion mutant (Euroscarf collection), that is viable, but has a lower growth rate compared to the wild-type. This deletion strain has a different genetic background CEN.PK, in which a number of mutations inviable in the BY genetic background are viable in this one.

Plasmids containing recombination systems were: pRS314L, pRS314-LYΔNS, pRS314L-lacZ, pRS314GL-lacZ. Plasmid for expression of RNH1: pCM184-RNH1 and pCM189-RNH1. Plasmid for DNA damage analysis: pWJ1344 containing the tagged RAD52-YFP fusion ([Key Resources Table](#sec4.1){ref-type="sec"}).

### Analysis of Rad52-foci and recombination frequencies in *S. cerevisiae* {#sec4.4.16}

For Rad52 analysis, spontaneous Rad52-YFP foci in S/G2 cells from mid-log growing cultures carrying plasmid pWJ1344 or pWJ1213 were visualized and counted by fluorescence microscopy, as previously described ([@bib41]). More than 200 S/G2 cells from at least three independent transformants were analyzed. More than 200 S/G2 cells were analyzed in each experiment.

Recombination frequencies were determined by fluctuation tests ([@bib24]). Yeast cells were transformed with the indicated plasmids and were grown in selective synthetic medium for 3-5 days at 30°C. For each strain, the recombination frequencies are given as the average and standard deviation of the median recombination frequency value obtained from fluctuation tests performed in 3--4 different transformants using 6 independent colonies per transformant. Recombinants were selected as Leu+ colonies for the plasmid containing LEU2 truncated repeat systems.

### FISH in *S. cerevisiae* {#sec4.4.17}

mRNA export was determined by *in situ* hybridization in yeast cells with oligodT-Cy3 probes ([Key Resources Table](#sec4.1){ref-type="sec"}) as previously described ([@bib68]) with the following modifications. Cells were spheroplasted with 1mg 20T zymoliase at 30°C 10 min. washed and placed on the coated slides. Samples were hybridized with a 100 ng/sample oligodT (40xT) labeled with the Cy3 fluorochrome (Sigma) in hybridization buffer with 20% formamide (2X SSC, 20% formamide /2.5 mg/ml BSA/10 mM VRC containing a total of 100 ng of Cy3-oligodT, 100 μg g of sonicated salmon sperm DNA and 100 μg g of E.coli tRNA) for at least 3h at 30°C. Immunofluorescence images were acquired using a Leica DM6000 wide-field microscope and Leica DFC365FX camera.

### Miscellanea {#sec4.4.18}

Analysis of sensitivity to genotoxic agents, Western, and yeast cultures were performed using standard procedures.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

For γH2AX foci, anaphase bridges, cell cycle, apoptosis, recombination and Rad52 foci analyses, paired Student's t test (parametric) was used. For single-cell electrophoresis assays, nonparametric Mann--Whitney U-test was used. Data were analyzed with EXCEL (Microsoft) or GraphPad Prism software. The statistical test used in each experiment is mentioned in the figure legend. In general, a P value \< 0.05 was considered as statistically significant (^∗∗∗∗^p \< 0.0001; ^∗∗∗^p \< 0.001; ^∗∗^p \< 0.01; ^∗^p \< 0.05). Specific replicate numbers (n) for each experiment can be found in the corresponding figure legends. In all figures, means are plotted and SEM is represented as error bars.

Data and Code Availability {#sec4.6}
--------------------------

The accession number for the microarray analysis of gene expression and alternative splicing of MFAP1- and THOC1-depleted human cells reported in this paper is GEO: [GSE119412](ncbi-geo:GSE119412){#interref115}. The accession number for the transcription analysis by RNA-Seq of spp381-ts mutant reported in this paper is GEO: [GSE128010](ncbi-geo:GSE128010){#interref120}.

Supplemental Information {#app2}
========================

Document S1. Figures S1--S4 and Table S1Table S2. Genes Misregulated upon MFAP1 Depletion (p \< 0.05 and \|Linear Fold Change\| \> 1.5), Related to Figure 5Significantly enriched GO biological process terms of misregulated genes upon MFAP1 depletion (p \< 0.05 and Fold enrichment \> 1.5).Table S3. Genes Misregulated upon THOC1 Depletion (p \< 0.05 and \|Linear Fold Change\| \> 1.5), Related to Figure 5Table S4. Genes with Alternative Splicing Changes upon MFAP1 Depletion (p \< 0.01 and \|Splicing Index\| ≥ 2), Related to Figure 5DTable S5. Genes with Alternative Splicing Changes upon THOC1 Depletion (p \< 0.01 and \|Splicing Index\| ≥ 2), Related to Figure 5Table S6. Significantly Enriched GO Biological Process Terms of Genes with Alternative Splicing Changes upon MFAP1 Depletion (p \< 0.001 and Fold Enrichment \> 1.5), Related to Figure 5ETable S7. RNA-Seq Analysis of WT (YDR007W) and *spp381-ts* (YPH2622-2D-4B) Strains after Shift to 37°C, Related to Figure 6Genes miss-regulated in *spp381-ts* mutant versus WT (p \< 0.05 and \|linear fold change\| \> 1.5). Significantly-enriched GO biological process and cellular component terms of upregulated and downregulated genes in *spp381-ts* versus WT (p \< 0.05 and Fold enrichment \> 1.5). Intron signal changes in *spp381-ts* versus WT (p \< 0.05 and \|linear fold change splicing\| \> 1.5).Document S2. Article plus Supplemental Information

We thank C. Tous for technical assistance with two-hybrid analysis, A. Panek for a preliminary analysis of yeast mutants, and A. Bayona-Feliu for help in the bioinformatics analysis. Research was funded by the European Research Council (grant ERC2014 AdG669898 TARLOOP), the Spanish Ministry of Economy and Competitiveness (grant BFU2016-75058-P), the Junta de Andalucía Spain (grant BIO1238), and the European Union Regional Funds (FEDER). I.S.-A. was a recipient of a FPU pre-doctoral training grant from the Spanish Ministry of Education, Culture and Sports.

Author Contributions {#sec5}
====================

I.S.-A., S.I.B., A.G.R., and R.L. performed the experiments. M.P. and E.A. did the sequencing and bioinformatics analyses of the transcriptome and RNA-seq experiments. I.S.-A., R.L., and A.A. designed the experiments, analyzed the results, and wrote the manuscript. All authors read, discussed, and agreed with the final version of the manuscript.

Declaration of Interests {#sec6}
========================

The authors declare no competing interests.

Supplemental Information can be found online at <https://doi.org/10.1016/j.celrep.2019.07.010>.

[^1]: Lead Contact
